Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1986 4
1988 4
1989 6
1990 8
1991 5
1992 27
1993 46
1994 53
1995 72
1996 127
1997 167
1998 215
1999 249
2000 272
2001 290
2002 281
2003 331
2004 369
2005 404
2006 475
2007 448
2008 474
2009 446
2010 530
2011 536
2012 590
2013 547
2014 518
2015 475
2016 443
2017 447
2018 432
2019 220
2020 13
Text availability
Article attribute
Article type
Publication date

Search Results

8,474 results
Results by year
Filters applied: . Clear all
Page 1
Ivosidenib: First Global Approval.
Dhillon S. Dhillon S. Drugs. 2018 Sep;78(14):1509-1516. doi: 10.1007/s40265-018-0978-3. Drugs. 2018. PMID: 30209701 Free PMC article. Review.
Cytochrome P450 3A Induction Predicts P-glycoprotein Induction; Part 2: Prediction of Decreased Substrate Exposure After Rifabutin or Carbamazepine.
Lutz JD, Kirby BJ, Wang L, Song Q, Ling J, Massetto B, Worth A, Kearney BP, Mathias A. Lutz JD, et al. Clin Pharmacol Ther. 2018 Dec;104(6):1191-1198. doi: 10.1002/cpt.1072. Epub 2018 Apr 26. Clin Pharmacol Ther. 2018. PMID: 29569712 Free PMC article. Clinical Trial.
P-Glycoprotein (MDR1/ABCB1) Restricts Brain Penetration of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib, While Cytochrome P450-3A (CYP3A) Limits Its Oral Bioavailability.
van Hoppe S, Rood JJM, Buil L, Wagenaar E, Sparidans RW, Beijnen JH, Schinkel AH. van Hoppe S, et al. Mol Pharm. 2018 Nov 5;15(11):5124-5134. doi: 10.1021/acs.molpharmaceut.8b00702. Epub 2018 Oct 10. Mol Pharm. 2018. PMID: 30247919
Colchicine Pharmacokinetics and Mechanism of Action.
Angelidis C, Kotsialou Z, Kossyvakis C, Vrettou AR, Zacharoulis A, Kolokathis F, Kekeris V, Giannopoulos G. Angelidis C, et al. Curr Pharm Des. 2018;24(6):659-663. doi: 10.2174/1381612824666180123110042. Curr Pharm Des. 2018. PMID: 29359661 Review.
Cytochrome P450 3A Induction Predicts P-glycoprotein Induction; Part 1: Establishing Induction Relationships Using Ascending Dose Rifampin.
Lutz JD, Kirby BJ, Wang L, Song Q, Ling J, Massetto B, Worth A, Kearney BP, Mathias A. Lutz JD, et al. Clin Pharmacol Ther. 2018 Dec;104(6):1182-1190. doi: 10.1002/cpt.1073. Epub 2018 Apr 19. Clin Pharmacol Ther. 2018. PMID: 29569723 Free PMC article. Clinical Trial.
8,474 results
Jump to page
Feedback